Combined average of Moat (AI Resilience), Growth, and Valuation scores.
Moat Score
BWXT is the sole manufacturer of the reactors and naval fuel for every US Navy nuclear-powered submarine and aircraft carrier, and owns both of the only two privately held NRC Category I facilities licensed to store and process highly enriched uranium, a franchise funded under multi-year Naval Nuclear Propulsion Program contracts that no rival can bid for.
BWXT's moat is a government-sanctioned monopoly on naval nuclear propulsion hardware and highly enriched uranium processing:
- Sole Supplier to the Naval Nuclear Propulsion Program: BWXT manufactures the reactor components and the naval fuel (through Nuclear Fuel Services in Erwin, Tennessee) for the Virginia- and Columbia-class submarines and the Ford-class carriers, and its reactors power the Ohio, Seawolf, Los Angeles and Nimitz classes already in service. The Navy funds that work through multi-year contracts: about $2.1B of reactor-component awards in February 2025 and more than $1.4B in May 2026, the larger piece the first of five annual task orders available through 2030. There is no second source to re-compete with, so the contract flow is set by shipbuilding schedules, not by bids.
- Two of Two Category I HEU Licences: The Lynchburg, Virginia site and the Erwin, Tennessee site are the only two privately owned NRC Category I facilities licensed to store and process highly enriched uranium. That is why the NNSA routes HEU purification, conversion and downblending work to BWXT, and why the special-materials line and the HALEU downblending capability sit in the same company as the naval business. A new entrant would need security infrastructure, a Category I licence and the Navy's qualification, and none has tried.
- A Commercial Leg That Is Growing Faster: Commercial Operations (CANDU steam generators and components, field services, fuel handling, the Kinectrics engineering and testing business and, from July 2026, Precision Components Group) grew 72% in Q2 2026, 33% organically, and management guides the segment to roughly 45% growth for 2026. It is a real but contested business, competing with Framatome, Westinghouse and Curtiss-Wright, and the medical isotope unit is being sold to Nordic Capital for up to $800M, which narrows BWXT back to nuclear components, fuel and services.
Moat Verdict
BWXT is a modest net beneficiary of AI: data-centre power demand supports the commercial nuclear new-build and refurbishment cycle its Commercial Operations segment sells into, while nothing in its core work can be automated away. Its moats, the two Category I HEU licences and sole-source naval reactor embedding, are physical and regulatory and fully AI-resilient; the AI-vulnerable pillars are mostly inapplicable, and the real risks are budget timing and shipyard schedules, not technology.
83.7 resilient · 65.0 vulnerable · 80/20 = 80.0 · = 80
Open a moat to read its note.
BWXT sells reactor components, naval fuel and nuclear services to the Navy, the NNSA and utilities; there is no user-trained interface or workflow, so this category does not apply.
Not software business logic: reactor-component manufacturing and HEU processing are physical know-how, rated under regulatory lock-in and transaction embedding, the Cameco precedent (M7).
BWXT controls no public data source; this category does not apply to a nuclear manufacturer.
Cleared nuclear machinists, welders and HEU-qualified operators take years to train and clear, and BWXT's naval workforce is the only one doing this work. It stays intact rather than LMT's strong because BWXT has published no figure for the size of its cleared workforce or its scarcity, and the Electric Boat, HII and national-laboratory nuclear workforce draws from the same pool (M8).
Reactor components, naval fuel, special materials and commercial field services and engineering come from one supplier, which helps on the commercial side, but there is no attach or renewal figure to show the bundle itself retains customers (M9).
Decades of manufacturing qualification and inspection data on naval reactor components are valuable, but the reactor designs belong to the Navy's Naval Reactors programme and its laboratories, not to BWXT. That is why this stays intact where TransDigm rates strong: TransDigm owns the part designs and their certification data.
BWXT's Lynchburg and Erwin sites are the only two privately owned NRC Category I facilities licensed to store and process highly enriched uranium, so 2 of 2 such licences sit in one company and no peer clears the barrier (M4). That is why this is strong where LMT's DoD clearances, held by every defense prime, are intact; the same reasoning as Centrus's sole HALEU licence.
Reactor components and fuel are sold programme by programme; one customer's purchase does not make the product more valuable to another.
BWXT is the sole manufacturer of naval reactor components and fuel for every US nuclear-powered submarine and carrier class, funded through multi-year contracts (about $2.1B in February 2025 and more than $1.4B in May 2026, the first of five annual task orders through 2030) with no second source to re-compete. This rates the contract flow; the licence that makes it possible is rated under regulatory lock-in. Same rating as LMT's sole-source programme embedding.
BWXT is a hardware and fuel supplier and is not the authoritative record for any information function, the same call as Moog.
Not a source of durability here: in naval work BWXT has no rival to hold a cost lead over, and in commercial components Framatome and Westinghouse operate at larger scale, so its position rests on licence and incumbency, not unit cost.
B2B and government supplier; awards are won on qualification and licences, not a brand premium.
Combined average of Moat (AI Resilience), Growth, and Valuation scores.
Moat Score
BWXT is the sole manufacturer of the reactors and naval fuel for every US Navy nuclear-powered submarine and aircraft carrier, and owns both of the only two privately held NRC Category I facilities licensed to store and process highly enriched uranium, a franchise funded under multi-year Naval Nuclear Propulsion Program contracts that no rival can bid for.
Growth Score
Q2 2026 revenue rose 18% to $901.6M (9% organic): Government Operations grew 2% to $601.3M on naval propulsion and special materials, partly offset by lower advanced-nuclear volume, while Commercial Operations rose 72% to $302.5M (33% organic) on commercial nuclear components, field services and Kinectrics. Adjusted EBITDA rose only 7% to $155.5M, so the quarter's margin fell on mix and Government Operations operating income slipped 3% to $105.7M. Management raised 2026 guidance to ~$3.8B revenue, $662–672M adjusted EBITDA, $4.70–4.80 non-GAAP EPS and $345–360M free cash flow, and at its September 29 Investor Day set 2030 targets of $5.5–6.0B revenue and $1.1–1.2B adjusted EBITDA (about 20% margin from 17.5% in 2026).
Valuation Score
At ~$143.83 (October 9, 2026 close), down about 40% from the $241.82 52-week high after estimate cuts and a sector de-rating rather than an operating miss, BWXT trades at ~30× the $4.70–4.80 FY2026 EPS guide and ~28× FY2027 consensus of ~$5.18. The ladder is struck on FY2027 EPS of ~$5.20: bear $115 (~22×), base $170 (~33×, near the multiple the stock held before the run-up) and bull $240 (a return to the high, ~40× an FY2028 that tracks the 2030 targets). The price sits ~25% above bear and ~15% below base. The base sits well below the Street (~$225 median), which is still anchored on pre-drawdown multiples; LMT, the closest defense comparator, is struck at ~20× and the gap is the sole-source naval franchise and faster growth.
The Naval Reactor Monopoly
BWXT's moat is a government-sanctioned monopoly on naval nuclear propulsion hardware and highly enriched uranium processing:
- Sole Supplier to the Naval Nuclear Propulsion Program: BWXT manufactures the reactor components and the naval fuel (through Nuclear Fuel Services in Erwin, Tennessee) for the Virginia- and Columbia-class submarines and the Ford-class carriers, and its reactors power the Ohio, Seawolf, Los Angeles and Nimitz classes already in service. The Navy funds that work through multi-year contracts: about $2.1B of reactor-component awards in February 2025 and more than $1.4B in May 2026, the larger piece the first of five annual task orders available through 2030. There is no second source to re-compete with, so the contract flow is set by shipbuilding schedules, not by bids.
- Two of Two Category I HEU Licences: The Lynchburg, Virginia site and the Erwin, Tennessee site are the only two privately owned NRC Category I facilities licensed to store and process highly enriched uranium. That is why the NNSA routes HEU purification, conversion and downblending work to BWXT, and why the special-materials line and the HALEU downblending capability sit in the same company as the naval business. A new entrant would need security infrastructure, a Category I licence and the Navy's qualification, and none has tried.
- A Commercial Leg That Is Growing Faster: Commercial Operations (CANDU steam generators and components, field services, fuel handling, the Kinectrics engineering and testing business and, from July 2026, Precision Components Group) grew 72% in Q2 2026, 33% organically, and management guides the segment to roughly 45% growth for 2026. It is a real but contested business, competing with Framatome, Westinghouse and Curtiss-Wright, and the medical isotope unit is being sold to Nordic Capital for up to $800M, which narrows BWXT back to nuclear components, fuel and services.
Moat Verdict
BWXT is a modest net beneficiary of AI: data-centre power demand supports the commercial nuclear new-build and refurbishment cycle its Commercial Operations segment sells into, while nothing in its core work can be automated away. Its moats, the two Category I HEU licences and sole-source naval reactor embedding, are physical and regulatory and fully AI-resilient; the AI-vulnerable pillars are mostly inapplicable, and the real risks are budget timing and shipyard schedules, not technology.
83.7 resilient · 65.0 vulnerable · 80/20 = 80.0 · = 80
Open a moat to read its note.
BWXT sells reactor components, naval fuel and nuclear services to the Navy, the NNSA and utilities; there is no user-trained interface or workflow, so this category does not apply.
Not software business logic: reactor-component manufacturing and HEU processing are physical know-how, rated under regulatory lock-in and transaction embedding, the Cameco precedent (M7).
BWXT controls no public data source; this category does not apply to a nuclear manufacturer.
Cleared nuclear machinists, welders and HEU-qualified operators take years to train and clear, and BWXT's naval workforce is the only one doing this work. It stays intact rather than LMT's strong because BWXT has published no figure for the size of its cleared workforce or its scarcity, and the Electric Boat, HII and national-laboratory nuclear workforce draws from the same pool (M8).
Reactor components, naval fuel, special materials and commercial field services and engineering come from one supplier, which helps on the commercial side, but there is no attach or renewal figure to show the bundle itself retains customers (M9).
Decades of manufacturing qualification and inspection data on naval reactor components are valuable, but the reactor designs belong to the Navy's Naval Reactors programme and its laboratories, not to BWXT. That is why this stays intact where TransDigm rates strong: TransDigm owns the part designs and their certification data.
BWXT's Lynchburg and Erwin sites are the only two privately owned NRC Category I facilities licensed to store and process highly enriched uranium, so 2 of 2 such licences sit in one company and no peer clears the barrier (M4). That is why this is strong where LMT's DoD clearances, held by every defense prime, are intact; the same reasoning as Centrus's sole HALEU licence.
Reactor components and fuel are sold programme by programme; one customer's purchase does not make the product more valuable to another.
BWXT is the sole manufacturer of naval reactor components and fuel for every US nuclear-powered submarine and carrier class, funded through multi-year contracts (about $2.1B in February 2025 and more than $1.4B in May 2026, the first of five annual task orders through 2030) with no second source to re-compete. This rates the contract flow; the licence that makes it possible is rated under regulatory lock-in. Same rating as LMT's sole-source programme embedding.
BWXT is a hardware and fuel supplier and is not the authoritative record for any information function, the same call as Moog.
Not a source of durability here: in naval work BWXT has no rival to hold a cost lead over, and in commercial components Framatome and Westinghouse operate at larger scale, so its position rests on licence and incumbency, not unit cost.
B2B and government supplier; awards are won on qualification and licences, not a brand premium.
Growth Analysis
Growth Drivers
Key Risk
If FY2027 defense appropriations run on an extended continuing resolution, or Columbia- and Virginia-class build rates slip further at the shipyards through 2027, naval component deliveries convert from the $8.4B backlog more slowly and the 2030 revenue target of $5.5–6.0B moves out of reach.
Score Derivation
74.3 base − 5 risk = 69
Base 74.3 (9–13% CAGR, midpoint 11%) + 0 trajectory (Commercial Ops accelerating, naval propulsion and special materials stable, advanced nuclear decelerating) + 0 stable margin (FY2026 adjusted EBITDA margin guide ~17.5% against ~17.9% in 2025; Q2's dip is acquisition mix, and the 2030 ~20% target is not yet in the numbers) − 5 moderate keyRisk (defense appropriations timing, graded with LMT, which shares the budget risk; lower than CCJ and LEU because BWXT's demand is funded naval programmes rather than uranium prices or SMR deployment) = 69
Price Scenarios (12–24 Months)
Price vs Targets
Dashed lines mark the 12–24 month bear, base and bull targets. Daily closes.
Valuation Analysis
Net debt was about $1.4B at June 30, 2026 (~$608M cash against ~$2.02B long-term debt), before the up-to-$800M medical sale expected to close by year-end. At ~$143.83 the risk/reward is roughly 20% downside to bear ($115) against 18% upside to base ($170) and 67% to bull ($240). $170.
Valuation Multiples
| Forward P/E (FY2026 guide) | ~30× |
| Forward P/E (FY2027) | ~28× |
| PEG Ratio | ~2.3× |
| Price / Sales | ~3.5× |
| Price / FCF | ~37× |
At ~28× FY2027 earnings BWXT is expensive against defense primes (LMT ~17×) but no longer against its own history after a 40% drawdown. A PEG near 2.3× says the multiple still pays for scarcity, not for growth alone; the low-teens revenue path to 2030 with margin expansion toward 20% is what has to carry it. Earnings are guided to grow faster than revenue, so the forward multiple compresses if the 2030 targets hold.
Approximate figures as of October 2026 (price ~$143.83).
Where We Are vs Targets
Loading live price…
Defense budget friction and slower submarine build rates stretch naval deliveries, the commercial segment's acquired growth fades into a high-single-digit organic rate, and the market pays a defense-contractor multiple of about 22× FY2027 EPS.
- An extended FY2027 continuing resolution or a Columbia/Virginia schedule slip at General Dynamics Electric Boat and HII pushes naval component revenue growth to low single digits through 2027
- Commercial Operations organic growth slows below 10% once Kinectrics and PCG are lapped, as Canadian refurbishment work peaks and new-build orders stay slow
- Adjusted EBITDA margin stays near 17.5% instead of moving toward the 20% 2030 target, and FY2027 EPS lands closer to $5.00 than $5.20
Naval propulsion compounds on funded multi-year contracts, Commercial Operations grows double digits, FY2027 EPS reaches about $5.20, and the stock re-rates to about 33× as the drawdown's estimate cuts prove smaller than feared.
- Annual NNPP task orders under the May 2026 award (first of five through 2030) are exercised on schedule and Government Operations returns to mid-to-high single-digit growth
- Commercial Operations delivers its ~45% 2026 guide and double-digit organic growth in 2027 on CANDU refurbishment, field services and PCG
- The medical sale closes by year-end, adding up to $800M of proceeds that cut net debt of ~$1.4B or fund nuclear capacity
The AUKUS and US submarine build-up, new HEU and enrichment work for the NNSA, and a commercial new-build cycle push BWXT ahead of its 2030 path, and the stock regains its 52-week high at about 40× FY2028 earnings.
- Submarine build rates rise toward the Navy's two-Virginia-plus-one-Columbia goal, lifting reactor-component and fuel volume above the 2030 plan
- Special materials and defense enrichment awards expand the Government Operations backlog well beyond $8.4B
- Commercial reactor new-builds in Canada and the US turn into component orders, and adjusted EBITDA margin reaches ~20% ahead of 2030